Pressmeddelande -

Pharma Consulting Group appoints new Senior Regulatory Advisor

Pharma Consulting Group (PCG) AB, a leading Swedish CRO and EDC provider, has appointed Gunnar Danielsson, as its new Senior Regulatory Advisor. Danielsson will start in his new role on August 1.

Danielsson will work closely with both sides of PCG – PCG Clinical Services and PCG Solutions.

Danielsson has more than 25 years of experience from the clinical research field in the pharmaceutical industry. During this time he has held various positions including monitoring, project leadership and auditing, as well as process implementation.

He has worked within local market companies as well as at the corporate level in Sweden, the UK and the US.

Since 2003, Danielsson has been a Pharmaceutical Inspector for the Swedish Medical Products Agency focusing on GCP inspection. In this capacity, he has conducted a large number of inspections in Sweden and internationally.

Danielsson has also given numerous presentations in the area of GCP both domestically and overseas. 


Ämnen

  • Hälsa, sjukvård, läkemedel

Kategorier

  • life sciences
  • ecrf-företag
  • kontraktsforskning
  • cro
  • pcg clinical services
  • pharma consulting group
  • gunnar danielsson
  • senior regulatory advisor

Regioner

  • Stockholm

Pharma Consulting Group AB (PCG) was formed by a group of entrepreneurs in 2003. With more than 100 years of experience in biostatistics, clinical research and data management, the management team is committed to delivering quality results for pharmaceutical, biotechnology and medical devices companies in the Nordic region. The full-service CRO is staffed by a team of professionals that are experts in:

  • Designing, managing, monitoring and analysing successful studies
  • Covering all phases of studies
  • Conducting non-interventional and medical device trials

Kontakter

Relaterat innehåll